These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 53296)

  • 1. [Clinical comparison of plasma substitutes, dextran and hydroxyethyl starch].
    Hayashi K; Higashi H
    Masui; 1975 Sep; 24(9):853-9. PubMed ID: 53296
    [No Abstract]   [Full Text] [Related]  

  • 2. [Low-molecular-weight hydroxyethyl starch or low-molecular-weight dextran in acute inner ear disorders? A randomized comparative study].
    Pilgramm M; Vestner HJ; Schumann K
    Laryngol Rhinol Otol (Stuttg); 1986 Jul; 65(7):377-80. PubMed ID: 2427904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hemodilution in acute ischemic insults. Comparative study on the clinical and hemorheologic effectiveness of 10% HES 200/0.5 and 10% dextran 40].
    Schneider R; Hacke W; Kiesewetter H; Jung F
    Fortschr Med; 1985 Nov; 103(44):1031-4. PubMed ID: 2416658
    [No Abstract]   [Full Text] [Related]  

  • 4. To which extent is the clinical use of dextran, gelatin and hydroxyethyl starch influenced by the incidence and severity of anaphylactoid reactions?
    Collins JA; Litwin MS; Lutz H; Klose R; Ring J; Thorén L; Tschirren B; Lundsgaard-Hansen P
    Vox Sang; 1979; 36(1):39-49. PubMed ID: 85370
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antishock blood substitute based on hydroxyethyl starch].
    Polushina TV; Prostakova TM; Bogino NA
    Probl Gematol Pereliv Krovi; 1980 Mar; 25(3):40-4. PubMed ID: 6154296
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hemodilution in patients with stage IIb peripheral arterial occlusive disease: prospective randomized double-blind comparison of middle-molecular weight hydroxyethyl starch and low-molecular weight dextran solution].
    Kiesewetter H; Jung F; Blume J; Gerhards M
    Klin Wochenschr; 1987 Apr; 65(7):324-30. PubMed ID: 2438451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dextran 40 or HES 200/0.5? Hemorheology of the long-term treatment of ischemic cerebral attacks].
    Haass A; Kroemer H; Jäger H; Müller K; Decker I; Wagner EM; Schimrigk K
    Dtsch Med Wochenschr; 1986 Oct; 111(44):1681-6. PubMed ID: 2429818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [HES, dextran and gelatin--indications and tolerance].
    Laubenthal H; Sirtl C
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Apr; 33(4):251-5. PubMed ID: 9617425
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative study of low molecular dextran or hydroxyethyl starch as a volume substitute in hemodilution therapy].
    Kiesewetter H; Jung F; Blume J; Bulling B; Franke RP
    Klin Wochenschr; 1986 Jan; 64(1):29-37. PubMed ID: 2419635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular effects of various colloidal solutions during major abdominal surgery.
    Nishimura N; Hiranuma N; Sugi T
    Crit Care Med; 1983 Dec; 11(12):940-2. PubMed ID: 6196154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative investigations of hydroxyethyl starch and dextran 60 in Isovolaemic haemodilution and haemorrhagic shock of rats (author's transl)].
    Hölscher B; Edeling M; Fahrmeier G; Kagel S
    Anaesthesist; 1975 May; 24(5):215-8. PubMed ID: 56902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effects of 500 ml 10% hydroxyethyl starch 200/0.5 and 10% dextran 40 on blood volume, colloid osmotic pressure and renal function in human volunteers (author's transl)].
    Köhler H; Zschiedrich H; Clasen R; Linfante A; Gamm H
    Anaesthesist; 1982 Feb; 31(2):61-7. PubMed ID: 6177264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Concerning the contribution by F. Jesch, G. Hübner, V. Zumtobel, M. Zimmermann and K. Messmer, hydroxyethyl starch (HAS 450/0,7) in plasma and liver--course of concentration and human histologic changes [Infusionstherapie 6:112-117 (1979)].
    Thompson WL
    Infusionsther Klin Ernahr; 1979 Aug; 6(4):262-3. PubMed ID: 90652
    [No Abstract]   [Full Text] [Related]  

  • 14. [Determination of the plasma elimination of hydroxyethyl starch and dextran using improved analytical methods].
    Förster H; Wicarkzyk C; Dudziak R
    Infusionsther Klin Ernahr; 1981 Apr; 8(2):88-94. PubMed ID: 6164643
    [No Abstract]   [Full Text] [Related]  

  • 15. [Blood volume replacement using hydroxyethyl starch or Dextran 60].
    Hölscher B
    Infusionstherapie (1973); 1974 Apr; 1(4):281-5. PubMed ID: 4142945
    [No Abstract]   [Full Text] [Related]  

  • 16. [Blood regeneration after blood substitution with dextran 60 or hydroxyethyl starch of an identical volume].
    Hölscher B; Kagel S
    Infusionsther Klin Ernahr; 1976 Aug; 3(4):250-3. PubMed ID: 60284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of low molecular hydroxyethyl starch (HES) on the kidney -- a comparison with low molecular dextran].
    Yamasaki H
    Masui; 1975 Jun; 24(6):580-600. PubMed ID: 51106
    [No Abstract]   [Full Text] [Related]  

  • 18. Rational use of albumin and plasma substitutes.
    Thompson WL
    Johns Hopkins Med J; 1975 May; 136(5):220-5. PubMed ID: 47936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of the plasma substitutes hydroxyethyl starch and dextrane-60 on the kidney function of dogs in acute haemorrhagic shock (author's transl)].
    Heidenreich O; aus der Mühlen K; Heintze K
    Anaesthesist; 1975 May; 24(5):239-43. PubMed ID: 56906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intravascular persistence, tissue storage and excretion of hydroxyethyl starch (HAS)].
    Thompson WL; Fukushima T; Rutherford RB; Walton RP
    Infusionsther Klin Ernahr; 1979 Jun; 6(3):151-5. PubMed ID: 88413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.